Skip to content

Author

Antonio Jimeno

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Dissociated response to immune checkpoint inhibition in head and neck squamous cell carcinoma is common and exhibits distinct clinical outcomes.

Immune checkpoint inhibition (ICI) constitutes the first-line therapy for relapsed/metastatic head and neck squamous cell carcinoma (HNSCC) despite low response rates. Some patients treated with ICI experience dissociated response (DR), the co-existence of responding and progression lesions. DR prevalence and prognosti...

Alice N. Weaver, S. Keysar, Aarti Dureja et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.